Ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate, 97%, 100mg

(9H-Fluoren-9-yl)methyl 3-hydroxypyrrolidine-1-carboxylate, 98%, 5g

3-(5-Bromo-1-oxoisoindolin-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)piperidine-2,6-dione, 500mg

L-VALINE-15N, 95.0%, 1g

2,2-Bis(trifluoromethyl)propionyl fluoride, 1g

5-(Pyrimidin-2-ylsulfanyl)-furan-2-carbaldehyde, 95.0%, 5g

1-(2,4-Dichloro-benzenesulfonyl)-2-methyl-piperazine hydrochloride, 95.0%, 250mg

2,2,2-Trifluoroethanol, min 99.8%, for synthesis, 1L, glass packaging

3-Amino-6-chloro-2-pyrazinecarbonitrile, 95.0%, 5g

1-(2-aminoethoxy)-2,3-dichlorobenzene hydrochloride, 2.5g

2-[(4-cyclopropanecarbonylpiperazin-1-yl)methyl]-2,3-dihydro-1,2-benzothiazol-3-one, 98%, 1mg

Refractive index standard BRIX , 10% stab. Sucrose, 1.34782 (20°C), 15mL

1-(TERT-BUTOXYCARBONYL)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 5g